BioMoti Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BioMoti Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11196
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioMoti Ltd (BioMoti) is a pharmaceutical company that offers cancer therapeutics that develops platform drug delivery technologies. The company provides products such as Oncojans a class of immunotherapeutic drug-loaded particles to target and gain entry into the tumour vasculature and cancer cells. It also provides MOTI1001 an Oncojan based ovarian cancer candidate. BioMoti has partnership with established drug developers to develop further API-Oncojan candidates, among others. The company’s Oncojans are new class immunotherapeutic drug loaded particles that gain entry to tumour vasculature and cancer cells, among others. It offers its products through its distributors across the UK. BioMoti is headquartered in London, the UK.

BioMoti Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioMoti Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioMoti Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioMoti Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioMoti Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioMoti Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BioMoti Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
BioMoti Raises USD0.6 Million in Venture Financing 10
BioMoti Raises USD1.1 Million in Venture Financing 11
Licensing Agreements 12
BioMoti Enters into Licensing Agreement with Queen Mary University of London 12
BioMoti Ltd – Key Competitors 13
BioMoti Ltd – Key Employees 14
BioMoti Ltd – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
BioMoti Ltd, Pharmaceuticals & Healthcare, Key Facts 2
BioMoti Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioMoti Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioMoti Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioMoti Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
BioMoti Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BioMoti Raises USD0.6 Million in Venture Financing 10
BioMoti Raises USD1.1 Million in Venture Financing 11
BioMoti Enters into Licensing Agreement with Queen Mary University of London 12
BioMoti Ltd, Key Competitors 13
BioMoti Ltd, Key Employees 14

List of Figures
BioMoti Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioMoti Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioMoti Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioMoti Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioMoti Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioMoti Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioMoti Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioMoti Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[BioMoti Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CellaVision AB (CEVI):医療機器:M&Aディール及び事業提携情報
    Summary CellaVision AB (CellaVision) is a medical technology company that provides digital solutions for medical microscopy in hematology. The company helps hematology laboratories improve and transform the analysis of blood and other body fluids. It has expertise in digital image analysis, automate …
  • Dermapharm AG-製薬・医療分野:企業M&A・提携分析
    Summary Dermapharm AG (Dermapharm) is a pharmaceutical company that offers dermatological and allergy medicines. The company provides products for allergies, disinfection and wound treatment, skin and hair care, corticoids, minerals, osteoporosis, fungal infections, vaginal thrush, other preparation …
  • China High Speed Transmission Equipment Group Co Ltd (658):企業の財務・戦略的SWOT分析
    China High Speed Transmission Equipment Group Co Ltd (658) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the compa …
  • Jollibee Foods Corporation:企業の戦略・SWOT・財務情報
    Jollibee Foods Corporation - Strategy, SWOT and Corporate Finance Report Summary Jollibee Foods Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Collegium Pharmaceutical Inc (COLL):企業の財務・戦略的SWOT分析
    Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • iCardiac Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary iCardiac Technologies Inc (iCardiac) is a provider of medical laboratory services. The company’s services portfolio include cardiac safety and respiratory services, cardiac safety assessment methodology, clinical trials, electrophysiology, drug development, regulatory services, protocol deve …
  • Sky plc (SKY):企業の財務・戦略的SWOT分析
    Sky plc (SKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Rite Aid Corporation:企業の戦略・SWOT・財務分析
    Rite Aid Corporation - Strategy, SWOT and Corporate Finance Report Summary Rite Aid Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bioconnect Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Bioconnect Systems, Inc. (Bioconnect) is a medical device company that designs, manufactures and distributes surgical and medical products. The company offers optiflow technology, which is used to provide quick joining vessels. Its technology also provides services such as control over the g …
  • Quarterhill Inc.:企業のM&A・事業提携・投資動向
    Quarterhill Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Quarterhill Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Dynemic Products Ltd.:企業の戦略・SWOT・財務情報
    Dynemic Products Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dynemic Products Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • EndoCeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary EndoCeutics Inc (EndoCeutics) is a pharmaceutical company that develops hormone sensitive cancer prevention therapies for women’s health. The company's pipeline products include drugs for various indications such as endometriosis, male hypogonadism and antiandrogens, among others. It develop …
  • Eng Kah Corporation Berhad:戦略・SWOT・企業財務分析
    Eng Kah Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Eng Kah Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • K&H Bank Zrt:企業の戦略・SWOT・財務情報
    K&H Bank Zrt - Strategy, SWOT and Corporate Finance Report Summary K&H Bank Zrt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Renaissance Offshore LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Renaissance Offshore LLC (Renaissance Offshore) is an oil and gas exploration and development company. The company carries out the business of identification and acquisition of under-developed oil and gas assets in the Gulf of Mexico. It builds and manages a portfolio of assets on oil produc …
  • Toma Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Toma Biosciences Inc (Toma Biosciences) is a biotechnology company that provides genome sequencing solutions. The company launched TOMA OS-Seq cancer assay to laboratories and researchers for the changes in tumors. Its products include reagent kits developed to detect genomic changes in canc …
  • Karambunai Corporation Berhad:戦略・SWOT・企業財務分析
    Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sunquest Information Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sunquest Information Systems Inc (Sunquest), a subsidiary of Roper Technologies, is a healthcare information technology (IT) company that provides diagnostic informatics solutions to laboratories and healthcare organizations worldwide. The company offers laboratory informatics such as labora …
  • Atmos Energy Corporation (ATO):石油・ガス:M&Aディール及び事業提携情報
    Summary Atmos Energy Corp (Atmos Energy) is a fully-regulated natural gas distributor. Together with its subsidiaries, the company delivers natural gas through regulated sales and transportation arrangements to residential, commercial, public authority and industrial customers.The company is also in …
  • St. George Bank:企業の戦略・SWOT・財務分析
    St. George Bank - Strategy, SWOT and Corporate Finance Report Summary St. George Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆